Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: Mechanistic links and clinical inferences

Journal of the American College of Cardiology

Volumn 65, Issue 20, 2015, Pages 2239-2251

  Hirsh, Benjamin J ^a   Copeland Halperin, Robert S ^a   Halperin, Jonathan L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

atrial appendage; atrial remodeling; cardiac arrhythmias; extracellular matrix; risk assessment; stroke

Indexed keywords

CLOPIDOGREL; EDOXABAN; GADOLINIUM; IRBESARTAN; WARFARIN;

AGE DISTRIBUTION; ATRIAL FIBRILLATION; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CONTROL; FIBROTIC ATRIAL CARDIOMYOPATHY; GENETIC PREDISPOSITION; HEART ARRHYTHMIA; HEART MUSCLE FIBROSIS; HOLISTIC CARE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MEDICAL RESEARCH; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINUS RHYTHM; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; VASCULAR DISEASE; CARDIOMYOPATHIES; COMPLICATION; FIBROSIS; FORECASTING; HEART ATRIUM; PATHOLOGY; RISK FACTOR; STROKE;

ATRIAL FIBRILLATION; CARDIOMYOPATHIES; FIBROSIS; FORECASTING; HEART ATRIA; HUMANS; RISK FACTORS; SIGNAL TRANSDUCTION; STROKE; THROMBOEMBOLISM;

EID: 84929643030     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.03.557     Document Type: Review

References (120)

1. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
2. A.M. Chamberlain, B.J. Gersh, and A. Alonso Decade-long trends in atrial fibrillation incidence and survival: a community study Am J Med 128 2015 260 267.e1
3. S.S. Chugh, R. Havmoeller, and K. Narayanan Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study Circulation 129 2014 837 847
4. D.E. Singer, Y. Chang, and L.H. Borowsky A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score J Am Heart Assoc 2 2013 e000250
5. S. Koton, A.L. Schneider, and W.D. Rosamond Stroke incidence and mortality trends in US communities, 1987 to 2011 JAMA 312 2014 259 268
6. J. Ball, M.J. Carrington, and J.J. McMurray Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century Int J Cardiol 167 2013 1807 1824
7. A. Jahangir, V. Lee, and P.A. Friedman Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study Circulation 115 2007 3050 3056
8. M. Disertori, M.G. Franzosi, and S. Barlera Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial BMC Cardiovasc Disord 13 2013 28
9. B.A. Steinberg, A.S. Hellkamp, and Y. Lokhnygina Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial Eur Heart J 36 2015 288 296
10. M. Brambatti, S.J. Connolly, M.R. Gold for the ASSERT Investigators Temporal relationship between subclinical atrial fibrillation and embolic events Circulation 129 2014 2094 2099
11. S. Nattel, and M. Harada Atrial remodeling and atrial fibrillation: recent advances and translational perspectives J Am Coll Cardiol 63 2014 2335 2345
12. J. Kajstura, M. Rota, and D. Cappetta Cardiomyogenesis in the aging and failing human heart Circulation 126 2012 1869 1881
13. P.J. Lijnen, V.V. Petrov, and R.H. Fagard Induction of cardiac fibrosis by transforming growth factor-beta(1) Mol Genet Metab 71 2000 418 435
14. C.C. Lin, J.L. Lin, and C.S. Lin Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation Chest 126 2004 1926 1932
15. G. Santulli, G. Iaccarino, and N. De Luca Atrial fibrillation and microRNAs Front Physiol 5 2014 15
16. H. Kottkamp Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications J Cardiovasc Electrophysiol 23 2012 797 799
17. N.F. Marrouche, D. Wilber, and G. Hindricks Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study JAMA 311 2014 498 506
18. A. Boldt, U. Wetzel, and J. Lauschke Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease Heart 90 2004 400 405
19. P.G. Platonov, L.B. Mitrofanova, and V. Orshanskaya Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age J Am Coll Cardiol 58 2011 2225 2232
20. A.W. Teh, P.M. Kistler, and G. Lee Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease J Cardiovasc Electrophysiol 23 2012 232 238
21. R.S. Oakes, T.J. Badger, and E.G. Kholmovski Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation Circulation 119 2009 1758 1767
22. H. Kottkamp Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy Eur Heart J 34 2013 2731 2738
23. A.W. Teh, P.M. Kistler, and G. Lee Long-term effects of catheter ablation for lone atrial fibrillation: Progressive atrial electroanatomic substrate remodeling despite successful ablation Heart Rhythm 9 2012 473 480
24. A. Goette, G. Juenemann, and B. Peters Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery Cardiovasc Res 54 2002 390 396
25. F. Gramley, J. Lorenzen, and C. Knackstedt Age-related atrial fibrosis Age (Dordr) 31 2009 27 38
26. C. Mahnkopf, T.J. Badger, and N.S. Burgon Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation Heart Rhythm 7 2010 1475 1481
27. D. Corradi Atrial fibrillation from the pathologist's perspective Cardiovasc Pathol 23 2014 71 84
28. J. Eckstein, S. Verheule, and N.M. de Groot Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria Prog Biophys Mol Biol 97 2008 435 451
29. U. Schotten, H.R. Neuberger, and M.A. Allessie The role of atrial dilatation in the domestication of atrial fibrillation Prog Biophys Mol Biol 82 2003 151 162
30. S. Nattel, and D. Dobrev The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities Eur Heart J 33 2012 1870 1877
31. D. MacKenna, S.R. Summerour, and F.J. Villarreal Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis Cardiovasc Res 46 2000 257 263
32. A. Bukowska, U. Lendeckel, and S.M. Bode-Boger Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation Cardiovasc Ther 30 2012 e115 e127
33. K. Suzuki, S. Imajoh, and Y. Emori Calcium-activated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function FEBS Lett 220 1987 271 277
34. D. Corradi, S. Callegari, and R. Maestri Structural remodeling in atrial fibrillation Nat Clin Pract Cardiovasc Med 5 2008 782 796
35. J. Jalife Mechanisms of persistent atrial fibrillation Curr Opin Cardiol 29 2014 20 27
36. B.A. Schoonderwoerd, H.J. Crijns, and D.J. van Veldhuisen Atrial natriuretic peptides during experimental atrial tachycardia: role of developing tachycardiomyopathy J Cardiovasc Electrophysiol 15 2004 927 932
37. F. Zhao, S. Zhang, and Y. Chen Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-beta1 levels in serum of patients with atrial fibrillation BMC Cardiovasc Disord 14 2014 167
38. A. Bukowska, U. Lendeckel, and D. Hirte Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation Cell Mol Life Sci 63 2006 333 342
39. J.D. Molkentin, J.R. Lu, and C.L. Antos A calcineurin-dependent transcriptional pathway for cardiac hypertrophy Cell 93 1998 215 228
40. J.M. Berry, V. Le, and D. Rotter Reversibility of adverse, calcineurin-dependent cardiac remodeling Circ Res 109 2011 407 417
41. J.G. Dickhout, R.E. Carlisle, and R.C. Austin Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis Circ Res 108 2011 629 642
42. H. Xiao, H. Lei, and S. Qin TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease Clin Cardiol 33 2010 149 156
43. M. Islam, J.F. Burke Jr., and T.A. McGowan Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction Kidney Int 59 2001 498 506
44. U. Canpolat, A. Oto, and T. Hazirolan A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy J Cardiovasc Electrophysiol 26 2015 251 259
45. B. Lei, H. Hitomi, and T. Mori Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts J Pharmacol Sci 117 2011 98 105
46. S.L. Yi, X.J. Liu, and J.Q. Zhong Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts PLoS One 9 2014 e85144
47. A. Frustacci, C. Chimenti, and F. Belloci Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
48. S. Ederhy, E. Di Angelantonio, and G. Dufaitre C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation Int J Cardiol 159 2012 40 46
49. Y. Guo, G.Y. Lip, and S. Apostolakis Inflammation in atrial fibrillation J Am Coll Cardiol 60 2012 2263 2270
50. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
51. S.C. Marott, B.G. Nordestgaard, and J. Zacho Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population J Am Coll Cardiol 56 2010 789 795
52. Y. Yashiro, T. Arimoto, and N. Hashimoto Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients Circ J 79 2014 61 69
53. D. Conen, P.M. Ridker, and B.M. Everett A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women Eur Heart J 31 2010 1730 1736
54. J.G. Akar, W. Jeske, and D.J. Wilber Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction J Am Coll Cardiol 51 2008 1790 1793
55. H. Cai, Z. Li, and A. Goette Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858
56. S.C. Dudley Jr., N.E. Hoch, and L.A. McCann Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 2005 1266 1273
57. L. Jesel, T. Arentz, and C. Herrera-Siklody Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation? J Cardiovasc Electrophysiol 25 2014 266 270
58. M. Hayashi, K. Takeshita, and Y. Inden Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction Thromb Res 128 2011 e113 e118
59. N. Takahashi, O. Kume, and O. Wakisaka Novel strategy to prevent atrial fibrosis and fibrillation Circ J 76 2012 2318 2326
60. O. Wakisaka, N. Takahashi, and T. Shinohara Hyperthermia treatment prevents angiotensin II-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72 J Mol Cell Cardiol 43 2007 616 626
61. J. Jalife Novel upstream approaches to prevent atrial fibrillation perpetuation Cardiol Clin 32 2014 637 650
62. J. Andrade, P. Khairy, and D. Dobrev The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms Circ Res 114 2014 1453 1468
63. O. Batal, P. Schoenhagen, and M. Shao Left atrial epicardial adiposity and atrial fibrillation Circ Arrhythm Electrophysiol 3 2010 230 236
64. C.X. Wong, H.S. Abed, and P. Molaee Pericardial fat is associated with atrial fibrillation severity and ablation outcome J Am Coll Cardiol 57 2011 1745 1751
65. S.N. Hatem, and P. Sanders Epicardial adipose tissue and atrial fibrillation Cardiovasc Res 102 2014 205 213
66. H.S. Abed, C.S. Samuel, and D.H. Lau Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation Heart Rhythm 10 2013 90 100
67. R.K. Pathak, M.E. Middeldorp, and D.H. Lau Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study J Am Coll Cardiol 64 2014 2222 2231
68. M.T. Ziolo, and P.J. Mohler Defining the role of oxidative stress in atrial fibrillation and diabetes J Cardiovasc Electrophysiol 26 2015 223 225
69. S. Mahida Transcription factors and atrial fibrillation Cardiovasc Res 101 2014 194 202
70. A. Chinchilla, H. Daimi, and E. Lozano-Velasco PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis Circ Cardiovasc Genet 4 2011 269 279
71. M.A. Balouch, M.J. Kolek, and D. Darbar Improved understanding of the pathophysiology of atrial fibrillation through the lens of discrete pathological pathways Glob Cardiol Sci Pract 2014 2014 24 36
72. L. Davies, J. Jin, and W. Shen Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age J Am Heart Assoc 3 2014 e000340
73. S. Cardin, E. Libby, and P. Pelletier Contrasting gene expression profiles in two canine models of atrial fibrillation Circ Res 100 2007 425 433
74. A. Ramadeen, G. Laurent, and C.C. dos Santos n-3 polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy Heart Rhythm 7 2010 520 528
75. A. Mochizuki, S. Yuda, and Y. Oi Assessment of left atrial deformation and synchrony by three-dimensional speckle-tracking echocardiography: comparative studies in healthy subjects and patients with atrial fibrillation J Am Soc Echocardiogr 26 2013 165 174
76. D.W. den Uijl, V. Delgado, and M. Bertini Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation Heart 97 2011 1847 1851
77. J.J. Bax, N.A. Marsan, and V. Delgado Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation Heart 101 2015 94 100
78. B.D. Hoit Left atrial size and function: role in prognosis J Am Coll Cardiol 63 2014 493 505
79. C. McGann, N. Akoum, and A. Patel Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI Circ Arrhythm Electrophysiol 7 2014 23 30
80. M. Daccarett, T.J. Badger, and N. Akoum Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation J Am Coll Cardiol 57 2011 831 838
81. E. Appelbaum, and W.J. Manning Left atrial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance predicts recurrence of atrial fibrillation after pulmonary vein isolation: do you see what I see? Circ Arrhythm Electrophysiol 7 2014 2 4
82. M. Sramko, P. Peichl, and D. Wichterle Clinical value of assessment of left atrial late gadolinium enhancement in patients undergoing ablation of atrial fibrillation Int J Cardiol 179 2015 351 357
83. L. Di Biase, P. Santangeli, and M. Anselmino Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study J Am Coll Cardiol 60 2012 531 538
84. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
85. R.G. Hart, L.A. Pearce, and R. McBride for the The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials Stroke 30 1999 1223 1229
86. D.M. Lloyd-Jones Cardiovascular risk prediction: basic concepts, current status, and future directions Circulation 121 2010 1768 1777
87. J.B. Olesen, C. Torp-Pedersen, and M.L. Hansen The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study Thromb Haemost 107 2012 1172 1179
88. 2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation Circulation 126 2012 860 865
89. J.L. Blackshear, L.A. Pearce, and R.G. Hart Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications Stroke 30 1999 834 840
90. G.Y. Lip, and J.L. Halperin Improving stroke risk stratification in atrial fibrillation Am J Med 123 2010 484 488
91. S. Goto, D.L. Bhatt, J. Rother for the REACH Registry Investigators Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis Am Heart J 156 2008 855 863.e2
92. Z. Hijazi, J. Oldgren, and A. Siegbahn Biomarkers in atrial fibrillation: a clinical review Eur Heart J 34 2013 1475 1480
93. S. Inoue, Y. Murakami, and K. Sano Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation J Card Fail 6 2000 92 96
94. D.C. Plitt, E.H. Chung, and J.P. Mounsey Relation of atrial fibrillation burden and N-terminal pro-brain natriuretic peptide Am J Cardiol 111 2013 1315 1318
95. J. Andersson, M. Rosenqvist, and P. Tornvall NT-proBNP predicts maintenance of sinus rhythm after electrical cardioversion Thromb Res 135 2015 289 291
96. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
97. N. Akoum, G. Fernandez, and B. Wilson Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation J Cardiovasc Electrophysiol 24 2013 1104 1109
98. M.F. Swartz, G.W. Fink, and M.F. Sarwar Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation J Am Coll Cardiol 60 2012 1799 1806
99. K.M. Gurses, M.U. Yalcin, and D. Kocyigit M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation Europace 17 2015 239 246
100. T.V. Glotzer, A.S. Hellkamp, J. Zimmerman for the MOST Investigators Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) Circulation 107 2003 1614 1619
101. M. Santini, M. Gasparini, M. Landolina for the Cardiological Centers Participating in the ClinicalService Project Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators J Am Coll Cardiol 57 2011 167 172
102. G.L. Botto, L. Padeletti, and M. Santini Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events J Cardiovasc Electrophysiol 20 2009 241 248
103. T.V. Glotzer, E.G. Daoud, and D.G. Wyse The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
104. J.S. Healey, S.J. Connolly, M.R. Gold for the ASSERT Investigators Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
105. J. Ip, A.L. Waldo, G.Y. Lip for the IMPACT Investigators Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort Am Heart J 158 2009 364 370.e1
106. D.T. Martin, M.M. Bersohn, and A.L. Waldo Randomized trial of atrial arrhythmia monitoring to guide anticoagulation Eur Heart J 2015 Apr 23 [E-pub ahead of print]
107. M.E. Goldman, L.A. Pearce, and R.G. Hart Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study) J Am Soc Echocardiogr 12 1999 1080 1087
108. V. Fuster, B.J. Gersh, and E.R. Giuliani The natural history of idiopathic dilated cardiomyopathy Am J Cardiol 47 1981 525 531
109. D.R. Holmes, V.Y. Reddy, Z.G. Turi for the PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
110. D.R. Holmes Jr., S. Kar, and M.J. Price Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial J Am Coll Cardiol 64 2014 1 12
111. I.C. Van Gelder, V.E. Hagens, H.A. Bosker for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
112. D.G. Wyse, A.L. Waldo, J.P. DiMarco for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
113. D.E. Singer, P. Ziegler, and S. Schmitt Paroxysmal atrial fibrillation poses a large but transient increase in ischemic stroke risk: a case-crossover study J Am Coll Cardiol 65 Suppl 10 2015 A314
114. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study JAMA 279 1998 1273 1277
115. S.B. Freedman, B.J. Gersh, and G.Y. Lip Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation Eur Heart J 36 2015 653 656
116. C.B. de Vos, R. Pisters, and R. Nieuwlaat Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis J Am Coll Cardiol 55 2010 725 731
117. J. Reiffel, A. Verma, and J.L. Halperin Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients Am Heart J 167 2014 22 27
118. ACTIVE Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
119. ACTIVE Writing Group of the ACTIVE Investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
120. R.P. Giugliano, C.T. Ruff, E. Braunwald for the ENGAGE AF-TIMI 48 Investigators Edoxaban versus warfarin in patients with atrial fibrillation N Engl J Med 369 2013 2093 2104